MLPA® Kits

For a description how to create and adapt MLPA Kits, that are not available on this page, please have a look at our User Manual MLPA.

 

Import of SALSA MLPA® kit descriptions via the SEQUENCE Pilot operation "Mixes [master file] / button [Import]".

Mix
Version
Date
Region
Application
P240-A2 Vs. 07 17-12-2012 CHEK1, BRIP1 Cancer
P240-A3 Vs. 09 11-07-2014 CHEK1, BRIP1 Cancer
P240-A3 Vs. 10 26-08-2015 CHEK1, BRIP1 Cancer
P241-D2 Vs. 16 13-08-2013 HNF4A 20q13, GCK 7p13, HNF1A 12q24, IPF1 13q12, HNF1B 17q12, NEUROD1 2q31 Maturity-Onset Diabetes of the Young (MODY)
P241-D2 Vs. 17 20-11-2014 HNF4A 20q13, GCK 7p13, HNF1A 12q24, IPF1 13q12, HNF1B 17q12, NEUROD1 2q31 Maturity-Onset Diabetes of the Young (MODY)
P241-D2 Vs. 18 04-03-2015 HNF4A 20q13, GCK 7p13, HNF1A 12q24, IPF1 13q12, HNF1B 17q12, NEUROD1 2q31 Maturity-Onset Diabetes of the Young (MODY)
P241-D2 Vs. 19 15-07-2015 HNF4A 20q13, GCK 7p13, HNF1A 12q24, IPF1 13q12, HNF1B 17q12, NEUROD1 2q31 Maturity-Onset Diabetes of the Young (MODY)
P241-D2 Vs. 20 08-04-2016 HNF4A 20q13, GCK 7p13, HNF1A 12q24, IPF1 13q12, HNF1B 17q12, NEUROD1 2q31 Maturity-Onset Diabetes of the Young (MODY)
P241-D2 Vs. 21 11-04-2017 HNF4A 20q13, GCK 7p13, HNF1A 12q24, IPF1 13q12, HNF1B 17q12, NEUROD1 2q31 Maturity-Onset Diabetes of the Young (MODY)
P241-E1 Vs. E1-01 30-11-2017 HNF4A 20q13, GCK 7p13, HNF1A 12q24, IPF1 13q12, HNF1B 17q12, NEUROD1 2q31 Maturity-Onset Diabetes of the Young (MODY)
Vs. 03
05-10-2009
PRSS1 7q34, SPINK1 5q32 Hereditary Pancreatitis (HP)
Vs. 05
23-10-2011
PRSS1 7q34, SPINK1 5q32 Hereditary Pancreatitis (HP)
Vs. 07
01-03-2013
PRSS1 7q34, SPINK1 5q32 Hereditary Pancreatitis (HP)
Vs. 08
19-04-2013
PRSS1 7q34, SPINK1 5q32 Hereditary Pancreatitis (HP)
Vs. 09
15-04-2015
PRSS1 7q34, SPINK1 5q32 Hereditary Pancreatitis (HP)
Vs. 06
23-10-2011
SERPING1 11q12.1 Hereditary angioedema (HAE)
Vs. 07 17-12-2012 SERPING1 11q12.1 Hereditary angioedema (HAE)
Vs. 08 08-04-2014 SERPING1 11q12.1 Hereditary angioedema (HAE)
Vs. 09 24-08-2016 SERPING1 11q12.1 Hereditary angioedema (HAE)
Vs. 10 07-09-2017 SERPING1 11q12.1 Hereditary angioedema (HAE)
Vs. 07
10-05-2013
AIP 11q13, MEN1 11q13 Multiple endocrine neoplasia (MEN)
P244-C1 Vs. 08 16-09-2014 AIP 11q13, MEN1 11q13 Multiple endocrine neoplasia (MEN)
P244-C1 Vs. 09 28-04-2016 AIP 11q13, MEN1 11q13 Multiple endocrine neoplasia (MEN)
Vs. 29
09-03-2012
various Microdeletion syndromes
P245-B1 Vs. 30 16-09-2012 various Microdeletion syndromes
P245-B1 Vs. 32 26-11-2013 various Microdeletion syndromes
P245-B1 Vs. 33 16-09-2014 various Microdeletion syndromes
Vs. 08 20-06-2016 CXCR4, CX3CR1, CCR5, CCR2, CD4, CD209 Chemokines
P248-A2 Vs. 10 27-11-2012 MLH1 3p21.3, MSH2 2p21 Colon cancer, hereditary non-polyposis (HNPCC)
P248-A2 Vs. 11 17-12-2012 MLH1 3p21.3, MSH2 2p21 Colon cancer, hereditary non-polyposis (HNPCC)
P248-A2 Vs. 12 01-03-2013 MLH1 3p21.3, MSH2 2p21 Colon cancer, hereditary non-polyposis (HNPCC
P248-B1 Vs. 13 10-07-2015 MLH1 3p21.3, MSH2 2p21 Colon cancer, hereditary non-polyposis (HNPCC
Vs. 02
25-08-2008
17p, 18p, 19p, 20p Subtelomeric screening
Vs. 06
30-10-2011
17p, 18p, 19p, 20p Subtelomeric screening
Vs. 07
17-12-2012
17p, 18p, 19p, 20p Subtelomeric screening
P250-B1 Vs.16 18-11-2011 22q11 DiGeorge syndrome
P250-B1 Vs.17 18-11-2011 22q11 DiGeorge syndrome
P250-B2 Vs. 18 22-10-2013 22q11 DiGeorge syndrome
P250-B2 Vs. 19 13-10-2014 22q11 DiGeorge syndrome
P250-B2 Vs. 01 12-04-2016 22q11 DiGeorge syndrome
P250-B2 Vs. B2-02 10-02-2017 22q11 DiGeorge syndrome
Vs. 08
18-7-2011
1p36, 3p22/3p21.3 and 11q23 Neuroblastoma
Vs. 08
18-07-2011
2p24.1/MYCN, 2q33, 17p13/TP53, 17q Neuroblastoma
Vs. 06
26-01-2009
Chromosomes 4, 7, 9, 12, 14 Neuroblastoma
Vs. 08
18-07-2011
Chromosomes 4, 7, 9, 12, 14 Neuroblastoma
Vs. 03
16-09-2008
PSEN1 14q24.2 Alzheimer's disease (AD)
Vs. 05
24-12-2011
PSEN1 14q24.2 Alzheimer's disease (AD)
Vs. 06
20-12-2012
PSEN1 14q24.2 Alzheimer's disease (AD)
Vs. 08
04-12-2015
PSEN1 14q24.2 Alzheimer's disease (AD)
Vs. 02
18-09-2008
ALDOB 9q21 Fructose intolerance
Vs. 05
30-10-2011
ALDOB 9q21 Fructose intolerance
Vs. 06
30-10-2011
ALDOB 9q21 Fructose intolerance
Vs. 08
20-02-2015
ALDOB 9q21 Fructose intolerance
Vs. 04
19-09-2008
FLCN 17p11, Smith-Magenis syndrome region Birt-Hogg-Dube syndrome
Vs. 07
30-10-2011
FLCN 17p11, Smith-Magenis syndrome region Birt-Hogg-Dube syndrome
Vs. 09
11-09-2013
FLCN 17p11, Smith-Magenis syndrome region Birt-Hogg-Dube syndrome
P256-B3 Vs. 10 18-02-2016 FLCN 17p11, Smith-Magenis syndrome region Birt-Hogg-Dube syndrome
P256-B3 Vs. 11 12-12-2016 FLCN 17p11, Smith-Magenis syndrome region Birt-Hogg-Dube syndrome
Vs. 02
23-05-2008
DKC1 Xq28 Dyskeratosis congenita (DC)
Vs. 04
30-10-2011
DKC1 Xq28 Dyskeratosis congenita (DC)
Vs. 01
16-07-2008
SMARCB1 22q11.2 Rhabdoid tumors
P258-C1 Vs. 04 29-09-2011 SMARCB1 22q11.2 Rhabdoid tumors
P258-C1 Vs. 07 29-10-2014 SMARCB1 22q11.2 Rhabdoid tumors
P258-C1 Vs. 08 28-01-2016 SMARCB1 22q11.2 Rhabdoid tumors
Vs. 03
21-01-2010
RPS6KA3 Xp22.2-p22.1, PQBP1 Xq11.2 Coffin-Lowry Syndrome (CLS)
P259-B1 Vs. 04 04-11-2011 RPS6KA3 Xp22.2-p22.1, PQBP1 Xq11.2 Coffin-Lowry Syndrome (CLS)
P259-B1 Vs. 05 17-12-2012 RPS6KA3 Xp22.2-p22.1, PQBP1 Xq11.2 Coffin-Lowry Syndrome (CLS)
P259-B2 Vs. 06 07-02-2014 RPS6KA3 Xp22.2-p22.1, PQBP1 Xq11.2 Coffin-Lowry Syndrome (CLS)
P259-B3 Vs. 07 28-07-2017 RPS6KA3 Xp22.2-p22.1, PQBP1 Xq11.2 Coffin-Lowry Syndrome (CLS)